Sudden Cardiac Death: Definitions
|
|
- Adam Lane
- 5 years ago
- Views:
Transcription
1 Contemporary Epidemiology of Sudden Death: Insights from the Comprehensive UCSF SCD Study 23 October 2010 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Electrophysiology Section University of California, San Francisco Disclosures Major Research grant: NIH K12 RR Research grant: NIH/NHLBI R01 HL Minor Biotronik: Honorarium St. Jude Medical: Honorarium Sudden Death: Background 1/3 of SCA events are unwitnessed Impossible to restrict the definition of SCA to documented VF since rhythm at clinical presentation is unknown in many cases Operational criteria for SCA and SCD do not rely upon the cardiac rhythm at the time of the event Duration of symptoms (< 1 hr) prior to SCA generally defines the suddenness of death 1
2 Sudden Death: Definitions Out-of-hospital occurrence of a presumed sudden pulseless condition in the absence of evidence of a noncardiac condition (e.g., pulmonary, CVA, PE) as the cause of collapse WHO definition of SCD: Unexpected death within 1 h of symptom onset if witnessed Unexpected death within 24 h of having been observed alive and sx-free if unwitnessed Magnitude of Sudden Death in the U.S. 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104: SCD Rates in the Developed World 2
3 Etiology of Sudden Death Huikuri et al. N Engl J Med, Vol Surveillance of SCD in San Francisco County San Francisco County: 2007 population 756,976 Median age 36.5 years 49% female: 51% male 31% Asian, 8% Black, 44% Caucasian, 14% Hispanic/Latino By California state law, all out-of-hospital have to be reported to ME All cases without an attending physician willing or able to determine cause of death (i.e. ER deaths) are reported to ME Retrospective review of all ME death records for deaths meeting WHO SCD definition to determine incidence of SCD in 2007 Cases were excluded if : known history of non-cardiac chronic and/or terminal illness identifiable non-cardiac etiology at time of death (e.g., obvious recent drug use). Retrospective Review of all ME Deaths, SF 2007 Review of details of presentacon at death All SF ME Deaths N= 1420 WHO SCDs N=262 Tseng ZH, et al AHA Scientific Sessions
4 WHO SCDs in San Francisco County, 2007 Between January 1, 2007 and December 31, 2007: 262 cases of WHO SCD Incidence of 34.6 per 100,000 Previous estimates in homogeneous populations: /100,000 Mean age 61.3 years 30% female: 70% male 4.3% of overall mortality in San Francisco County 2007 SCD Rates in San Francisco County by Ethnicity Determination of Actual Sudden Arrhythmic Deaths How specific are WHO SCD criteria for actual arrhythmic sudden death? Panel of 3 physicians For each WHO SCD: review of all post-mortem ME investigations (prior hospital records, autopsy, toxicology, histology) Final cause of death adjudicated as Noncardiac (e.g. PE, CVA) non-arrhythmic sudden death (e.g., CHF, tamponade) sudden arrhythmic death 4
5 Determination of Sudden Arrhythmic Deaths Review of details of presentacon at death Review of full ME invescgacon (records, autopsy, toxicology) All SF ME Deaths N= 1420 WHO SCDs N=262 N=158 (60.3%) Non- N=104 (39.7%) Sudden Arrhythmic Death N=147 (56% of WHO SCDs) Non- Arrhythmic Sudden Death N=11 Tseng ZH, et al AHA Scientific Sessions 2009 Sudden Arrhythmic Death in San Francisco etiology accounted for 158 of 262 WHOdefined SCDs representing a rate of 20.9 per 100,000 Accuracy of WHO criteria for true cardiac etiology = 60.3% Accuracy of WHO criteria for arrhythmic etiology = 56.1% Most common non-cardiac causes of SCD were lethal drug or alcohol overdose, pulmonary disease, and cancer. Low PPV for True SAD WHO SCD SAD Cases Incidence (per 100,000) Mean Age Percent Male Overall Mortality (2007) 69.9% 70.1% 4.3% 2.4% Number of Cases WHO SCD v. SAD WHO SCD SAD PPV of WHO SCD criteria for true SAD = 56.1% Tseng ZH, et al AHA Scientific Sessions
6 140 SCD Rates in San Francisco, 2007 Rates of SCD per 100, SF 2007 WHO SCD SF 2007 SAD Chugh et al. (2004) de Vreede- Swagemakers Low Rate Becker et al. et al. (1997) (1993) High Rate Becker et al. (1993) 1. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: mulcple source surveillance versus retrospeccve death cercficate- based review in a large U.S. community. J Am Coll Cardiol. 2004;44(6): de Vreede- Swagemakers JJ, Gorgels AP, Dubois- Arbouw WI, van Ree JW, et al. Out- of- hospital cardiac arrest in the 1990s " a populacon- based study in the Maastricht area on incidence, characterisccs and survival. J Am Coll Cardiol 1997;30(6): Becker, LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evaluacng survival rates. Ann Emerg Med 1993;22(1): Tseng ZH et al AHA 2009 SCD/SAD Rates Vary Widely by Ethnicity and Sex Tseng ZH, et al AHA Scientific Sessions 2009 Sudden Arrhythmic Deaths vs. Control (Trauma) Deaths SF ME Deaths N=1420 WHO SCDs N=262 N=158 Non- N=104 Accidental Trauma deaths N=376 Autopsy N=238 Arrhythmic N=147 Non-arrhythmic N=11 Autopsy N=47 6
7 CAD in SADs vs. Controls Significant CAD was present in 39% of SADs and associated with higher SAD risk compared to control deaths (OR 2.58, 95% CI , p=0.026). Only 1 of 37 (2.7%) SADs and 0 of 192 controls had an active coronary lesion, p = 0.17 Interstitial Fibrosis in SADs vs. Trauma Controls 40x LV septum, trichrome stain 77yo AM trauma victim, minimal CAD 77yo AM SAD victim, minimal CAD Global interstitial fibrosis score 1.5-fold higher in SADs than controls, adjusted for age, sex, ethnicity, CAD level Epidemiologic Insights Thus Far WHO SCD criteria have a low PPV for SAD Blacks have 2.4-fold higher incidence of SAD than Caucasians Men have 2.3-fold higher incidence than women Active coronary lesion as the cause of SAD is far lower than previous estimates Significant CAD accounted for less than 40% of SADs, half of historical estimates Significant CAD still imparts a 2.5-fold higher risk of SAD Interstitial myocardial fibrosis is associated with SAD and may serve a useful risk stratifier Reflects contemporary epidemiology of SAD and CAD in a diverse community 7
8 Magnitude of Sudden Death in the U.S. 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104: Etiology of Sudden Death Adapted from Huikuri et al. N Engl J Med, Vol Sudden Arrhythmic Deaths vs. Control (Trauma) Deaths SF ME Deaths N=1420 WHO SCDs N=262 N=158 Non- N=104 Accidental Trauma deaths N=376 Autopsy N=238 Arrhythmic N=147 Non-arrhythmic N=11 Autopsy N=47 8
9 Comprehensive UCSF SCD Study 5 year study, collaboration with SF County ME 3 years of systematic autopsy evaluation of SCD compared to frequency-matched trauma controls Evaluation of morphometric parameters Heart weight LV septal thickness MV prolapse Evaluation of myocardial fibrosis Creation of DNA and cardiac tissue bank for future high-quality genetic and molecular studies Derive more accurate definition of SCD Inform policy for investigation of SCDs by MEs Acknowledgements UCSF EP Section Jeff Olgin Dan Steinhaus Dean Whiteman UCSF Epidemiology Stephen Hulley Eric Vittinghoff Feng Lin UCSF Program in Human Genetics Brad Aouizerat Ludmila Pawlikowska Annie Poon UCSF Genomic Resource in Atherosclerosis John Kane Mary Malloy Clive Pullinger SFFD/ SFGH Emergency Medicine Karl Sporer SF Medical Examiner s Office Ellen Moffatt Amy Hart UCSF Pathology Phil Ursell 9
Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study
Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study 8 September 2012 California Heart Rhythm Symposium Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine in Residence
More informationRole of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death
Role of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death 29 October 2011 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Associate
More informationSudden Cardiac Death and Asians Disclosures
Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University
More informationDEGREE (if applicable)
BIOGRAPHICAL SKETCH NAME: Chugh, Sumeet S., MD, FAHA, FHRS, FACC era COMMONS USER NAME (credential, e.g., agency login): chughs OMB No. 0925-0001/0002 (Rev. 08/12 Approved Through 8/31/2015) POSITION TITLE:
More informationCardiac, Physiologic, and Real World Effects of Taser Use
Cardiac, Physiologic, and Real World Effects of Taser Use 1 June 2017 Conducted Energy Device Meeting San Francisco Police Department Zian H. Tseng, M.D., M.A.S. Murray Davis Endowed Professor Associate
More informationRisk Stratification of Sudden Cardiac Death
Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of
More informationSudden Death in Athletes: What is the role of ECG Screening?
Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,
More informationEpidemiologic Methods in the Study of Sudden Cardiac Death
Epidemiologic Methods in the Study of Sudden Cardiac Death Clinical Epidemiology and Biostatistics Mahidol University Bangkok Ross J. Simpson Jr, MD, PhD Division of Cardiology University of North Carolina
More informationSudden Cardiac Death
Sudden Cardiac Death management challenges of a global problem Zayd A. Eldadah, MD, PhD Co-Director, Cardiac Electrophysiology, Washington Hospital Center Director, Cardiac Electrophysiology, Georgetown
More informationSudden Cardiac Death in Korea : Epidemiology and Risk Factors
Sudden Cardiac Death in Korea : Epidemiology and Risk Factors Seok-Min Kang, MD, Ph D. Director, Heart Failure & Cardiac Wellness Center, Professor, Division of Cardiology, Severance Cardiovascular Hospital,
More informationVentricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
More informationOut-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival
1500 JACC Vol. 30, No. 6 SUDDEN DEATH Out-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival JACQUELINE J. M. DE VREEDE-SWAGEMAKERS,
More informationOut-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry
European Heart Journal (2003) 24, 1204 1209 Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Anton P.M. Gorgels*, Claudia Gijsbers, Jacqueline de
More informationAblation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation
Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor
More informationSupplementary Online Content
Supplementary Online Content Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2641.
More informationZoll Medical--LifeVest:
Zoll Medical--LifeVest: Territory Manager: Sunny Brown Cell: (818) 916-6520 Objectives Why the LifeVest device exist Review indications for Wearable Cardioverter Defibrillator (WCD) use Give a brief description
More informationSudden Cardiac Death What an electrophysiologist thinks a cardiologist should know
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationSudden cardiac arrest How can we improve results of resuscitation?
Sudden cardiac arrest How can we improve results of resuscitation? 127 Applied Cardiopulmonary Pathophysiology 16: 127-132, 2012 Sudden cardiac arrest How can we improve results of resuscitation? Hein
More informationThe implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology
More informationSince 1995, the American Heart Association (AHA) has. AHA Science Advisory
AHA Science Advisory Lay Rescuer Automated External Defibrillator ( Public Access Defibrillation ) Programs Lessons Learned From an International Multicenter Trial Advisory Statement From the American
More informationJournal of the American College of Cardiology Vol. 47, No. 6, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 47, No. 6, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.045
More informationUpdate on Sudden Cardiac Death and Resuscitation
Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio
More informationCauses of nonischemic sudden cardiac death in the current era
Causes of nonischemic sudden cardiac death in the current era Eeva Hookana, MSc,* M. Juhani Junttila, MD, Veli-Pekka Puurunen, BM,* Jani T. Tikkanen, BM,* Kari S. Kaikkonen, MD,* Marja-Leena Kortelainen,
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationAsymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco
Asymptomatic Atrial Fibrillation: Detection and Management 18 December 2015 32 nd Annual Advances in Heart Disease Palace Hotel, San Francisco Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine
More informationUpdate on Sudden Cardiac Death and Resuscitation
Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio
More informationIncidence of and Survival from Sudden Cardiac Arrest
Incidence of and Survival from Sudden Cardiac Arrest Vincent N Mosesso, Jr, MD Professor of Emergency Medicine University of Pittsburgh School of Medicine Disclosures Employer: University of Pittsburgh
More informationPreventing Sudden Death Current & Future Role of ICD Therapy
Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationPrimary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life
Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge
More informationJSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE»
JSC «Astana Medical University» PhD THESIS ANNOTATION Specialty: 6D110100 «MEDICINE» Title: «Prognostic efficiency of sudden cardiac death s predictors in preserved and moderately reduced left ventricle
More informationWho does not need a primary preventive ICD?
Who does not need a primary preventive ICD? Hildegard Tanner, Bern Universitätsklinik für Kardiologie Disclosure of potential conflicts of interest Travel grants for educational purposes from: Biosense
More informationHF and CRT: CRT-P versus CRT-D
HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA
More informationDo All Patients With An ICD Indication Need A BiV Pacing Device?
Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology
More informationRisk of sudden cardiac death. Original Article
Risk of sudden cardiac death Roxana Sadeghi (1), Nadia Adnani (2), Mohammad-Reza Sohrabi (3), Saeed Alipour Parsa (1) Abstract Original Article BACKGROUND: The aim of this study was to determine characteristics
More informationSudden Cardiac Arrest
Sudden Cardiac Arrest Amit Sharma, MD, FACP, FACC Interventional Cardiologist Rockledge Regional Medical Center Assistant Professor of Medicine University of Central Florida Disclosures No relevant financial
More informationDisclosures (2013 to the present)
What level and types of CV safety data acquisition should be considered to sufficiently characterize a drug s benefit/risk assessment by the end of Phase 3 development? Cardiac Safety Research Consortium
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011
ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off
More informationBiomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.
Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D. Professor of Medicine Division of Cardiology University of California, San Diego Disclosures Honoraria, Research Grants, Medtronic Honoraria,
More informationWPW: Background 10/23/10. Asymptomatic Subjects with WPW Should Undergo Catheter Ablation:! Proponent
Asymptomatic Subjects with WPW Should Undergo Catheter Ablation:! Proponent Ronn E. Tanel, MD Director, Pediatric Arrhythmia Center Associate Professor of Pediatrics UCSF School of Medicine WPW: Background
More informationICD Therapy. Disclaimers
ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.
More informationSudden Cardiac Arrest and Death in United States Marathons
Sudden Cardiac Arrest and Death in United States Marathons David Webner, Kevin M. Duprey, Jonathan A. Drezner, Peter Cronholm, William O. Roberts Oct 24, 2012 Med Sci Sports Exerc. 2012;44(10):1843-1845.
More informationClinical aspects of Arrhythmogenic Cardiomyopathies
Clinical aspects of Arrhythmogenic Cardiomyopathies INTERNATIONAL CLINICAL CARDIOVASCULAR GENETICS CONFERENCE 25 May 2018 Dr Hari Raju MBChB PhD ECES FRACP Clinical Associate Professor, Macquarie University,
More informationConsensus Paper on Out-of-Hospital Cardiac Arrest in England
Consensus Paper on Out-of-Hospital Cardiac Arrest in England Date: 16 th October 2014 Revision Date: 16 th October 2015 Introduction The purpose of this paper is to bring some clarity to the analysis of
More informationEthnic Differences in Sudden Cardiac Arrest. Joanna Ghobrial. A Thesis submitted in partial fulfillment of the requirements for the degree of
Ethnic Differences in Sudden Cardiac Arrest Joanna Ghobrial A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2014 Committee: Susan
More informationEpidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C.
UvA-DARE (Digital Academic Repository) Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C. Link to publication Citation for published version (APA): van der Werf, C.
More informationClinical and Economic Value of Rivaroxaban in Coronary Artery Disease
CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban
More informationInterpretation and Consequences of Repolarisation Changes in Athletes
Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus
More informationSecondary prevention of sudden cardiac death
Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary
More informationPreoperative Cardiac Evaluation:
Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical
More informationAsymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱
Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱 Let It Be? Vs. Just Do It? Natural history of asymptomatic WPW Incidence of sudden cardiac death in natural history studies involving
More informationDevice Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI
Device Interrogation- Pacemakers, ICD and Loop Recorders Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Disclosures Consultant: Medtronic Speaker s Bureau: St. Jude Medical
More informationPrevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias
Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology
More informationΠρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:
Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation
More informationImpact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C
Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University
More informationSudden cardiac death (SCD) is a leading cause of cardiovascular
Smoking, Smoking Cessation, and Risk of Sudden Cardiac Death in Women Roopinder K. Sandhu, MD, MPH; Monik C. Jimenez, ScD; Stephanie E. Chiuve, ScD; Kathryn C. Fitzgerald, MSc; Stacey A. Kenfield, ScD;
More informationIntroduction To ACLS,1 18 April 2011 INTRODUCTION TO ACLS
Introduction To ACLS,1 INTRODUCTION TO ACLS EPIDEMIOLOGY In Singapore, every year about 2,400 people suffer from an acute myocardial infarction. Of these about 900 die as a result of sudden cardiac arrest,
More informationClinical Controversies in Perioperative Medicine
Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive
More informationCardiac MRI: Cardiomyopathy
Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD I do not have any relevant financial relationships with any commercial interests Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD Duke University Medical
More informationDisclosures. Advances in Cardiac Electrophysiology. CVA Risk by Type of AF. Outline
Disclosures Advances in Cardiac Electrophysiology Research Grant: NIH KL2 RR2413 Honoraria (minor): Biotronik St. Jude Medical Advances in Internal Medicine UCSF Department of Medicine, School of Medicine
More informationManagement of Syncope in Heart Failure. University of Iowa
Management of Syncope in Heart Failure Brian Olshansky University of Iowa 1 Syncope Transient loss of consciousness, with rapid, usually complete, recovery, with or without prodrome A common, non-specific,
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationVest Prevention of Early Sudden Death Trial (VEST)
ACC Late Breaking Clinical Trials 2018 Vest Prevention of Early Sudden Death Trial (VEST) Jeffrey Olgin, MD, FACC Division of Cardiology, UCSF On behalf of the VEST Investigators Disclosures ClinicalTrials.gov
More informationOut-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD
Out-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD Professor of Internal Medicine, Emergency Medicine, Therapeutics. Past President of the European Society for
More informationSudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia
Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen MD DMSc. Associate Professor and Head of inherited Arrhythmia Department of Cardiology, B 2142 Copenhagen University Hospital, Rigshospitalet,
More informationHot Topics in Cardiac Arrest. Should the patient go To the Cath Lab?
Hot Topics in Cardiac Arrest Should the patient go To the Cath Lab? Tim Russert 1950-2008 Host of NBC s Meet the Press Sudden Cardiac Arrest : Autopsy showed plaque rupture in his LAD ( per LA Times,
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationVentricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center
Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac
More informationWhere Does the Wearable Cardioverter Defibrillator (WCD) Fit In?
Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,
More informationAdvanced MR Imaging in Myocarditis
Naeem Merchant MD FRCP Professor of Medicine Department of Radiology Department of Cardiac Sciences Cumming School of Medicine University of Calgary Advanced MR Imaging in Myocarditis The Lake Louise Criteria
More informationWPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL
WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL W.P.W Clues in sinus rhythm No Q in Lt chest leads (WPW 88%, control 5%) PR < 100msec (WPW 80%, control
More informationAtrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology
Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance
More informationMethods Study population The design and objectives of CHS have been described elsewhere. 9 The CHS is a longitudinal study of 5,888 men
N-terminal pro-b-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study Kristen K. Patton, MD,* Nona Sotoodehnia, MD,* Christopher DeFilippi, MD, FACC, David
More informationSudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC
Sudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida Disclosures
More informationCulprit PCI vs MultiVessel PCI for Acute Myocardial Infarction
Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia
More informationMyocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD
Myocardial Injury after Noncardiac Surgery (MINS): What is it and what can we do to help patients suffering this event? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting
More informationFANS Paediatric Pathway for Inherited Arrhythmias*
FANS Paediatric Pathway for Inherited Arrhythmias* The pathway is based on the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
More informationInvestigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex
Investigating the family after a sudden cardiac death Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Sudden adult deaths subdivided Sudden Adult Death Sudden Cardiac Death Sudden Arrhythmic
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationTreatment of Arrhythmias in the Emergency Setting
Treatment of Arrhythmias in the Emergency Setting Zian H. Tseng, M.D. Assistant Professor of Medicine Cardiac Electrophysiology Section Cardiology Division University of California, San Francisco There
More informationSCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE
SCREENING AND PREVENTING SUDDEN CARDIAC DEATH IN EXERCISE Adj Assc Prof Tong Khim Leng MBBS MRCP FACC FASE FAMS FRCP Chief, Sn Consultant Department of Cardiology Changi General Hospital My Disclosures
More informationPrevention of Sudden Death in ARVC
ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück
More informationEndpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD
Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Professor of Cardiology/Medicine Director of the Heart Research Follow Up Program, University of Rochester, Rochester,
More informationPrimary Therapy for High Risk LQT Patients Should Be an ICD
Primary Therapy for High Risk LQT Patients Should Be an ICD Raul Weiss MD, FAHA, FACC, FHRS, CCDS Director, Electrophysiology Fellowship Program Associate Professor of Medicine The Ohio State University
More informationThe 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD
The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD Disclosures Consulting with St. Jude Medical, Boston Scientific, and Biotronik The 5 Most Important Things You Need
More informationJohnson County Emergency Medical Services Page 23
Non-resuscitation Situations: Resuscitation should not be initiated in the following situations: Prolonged arrest as evidenced by lividity in dependent parts, rigor mortis, tissue decomposition, or generalized
More informationSports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting
Sports Cardiology: Matters of the Heart AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Matthew Gammons, MD Vermont Orthopaedic Clinic Killington Medical Clinic Although sudden cardiac death is a relatively
More informationHIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD
HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting honorariums or other payments
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationNEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology
NEWLY DETECTED ATRIAL FIBRILLATION Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology 68 y/o woman complains of - generalized fatigue - mild DOE - never eats but keeps gaining
More informationTENNESSEE Project ADAM. Preventing Sudden Cardiac Death (SCD): Implementing your school s Public Access to Defibrillation (PAD) program.
TENNESSEE Project ADAM Preventing Sudden Cardiac Death (SCD): Implementing your school s Public Access to Defibrillation (PAD) program. In Tennessee IT S THE LAW. All schools equipped with an AED must
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationEVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington
EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?
More informationArthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.
Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography
More informationClinical Controversies in Perioperative Medicine
Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative
More informationAssessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis
Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis Investigator: Keiko Saito, MD Mentor: Yuji Saito, MD, PhD, FACP, FACC Department
More informationCARDIOLOGY GRAND ROUNDS
CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency
More information2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC
2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential
More information